Cite
Kindon N, Andrews G, Baxter A, et al. Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists. ACS Med Chem Lett. 2017;8(9):981-986doi: 10.1021/acsmedchemlett.7b00315.
Kindon, N., Andrews, G., Baxter, A., Cheshire, D., Hemsley, P., Johnson, T., Liu, Y. Z., McGinnity, D., McHale, M., Mete, A., Reuberson, J., Roberts, B., Steele, J., Teobald, B., Unitt, J., Vaughan, D., Walters, I., & Stocks, M. J. (2017). Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists. ACS medicinal chemistry letters, 8(9), 981-986. https://doi.org/10.1021/acsmedchemlett.7b00315
Kindon, Nicholas, et al. "Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists." ACS medicinal chemistry letters vol. 8,9 (2017): 981-986. doi: https://doi.org/10.1021/acsmedchemlett.7b00315
Kindon N, Andrews G, Baxter A, Cheshire D, Hemsley P, Johnson T, Liu YZ, McGinnity D, McHale M, Mete A, Reuberson J, Roberts B, Steele J, Teobald B, Unitt J, Vaughan D, Walters I, Stocks MJ. Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists. ACS Med Chem Lett. 2017 Sep 01;8(9):981-986. doi: 10.1021/acsmedchemlett.7b00315. eCollection 2017 Sep 14. PMID: 28947948; PMCID: PMC5601455.
Copy
Download .nbib